Bean plant polymer for treating diabetes
Researchers in China have developed a new class of glucose-responsive polymer nanogels using a protein extracted from beans that could potentially lead to self-regulating insulin carriers for the treatment of diabetes.
Currently, patients of type 1 and advanced type 2 diabetes must self-monitor their glucose levels and subsequently self-administer insulin to keep these levels balanced. This not only impinges on the patients’ quality of life, but also means that their insulin doses are not precisely controlled.
Using ConA as a key component – a plant lectin protein extracted from Jack beans that recognises glucose through a conformational change – the scientists produced a novel polymer nanogel that can undergo reversible and rapid volume phase transition to deliver the required amounts of insulin in response to fluctuations in blood glucose levels. The new gels show higher stabilities than any previously reported and could effectively modulate the in vitro delivery of pre-loaded insulin, negating the need for patients to monitor their glucose levels.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Biocartis announces its new CEO
